Gilead Sciences Announces First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
JPMorgan Downgrades Gilead Sciences (GILD) to Neutral
May 1, 2020 5:36 AM EDTJPMorgan analyst Cory Kasimov downgraded Gilead Sciences (NASDAQ: GILD) from Overweight to Neutral with a price target of $85.00.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $81.17 yesterday.
... MoreGilead Sciences (GILD) Tops Q1 EPS by 11c
April 30, 2020 4:07 PM EDTGilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.68, $0.11 better than the analyst estimate of $1.57. Revenue for the quarter came in at $5.55 billion versus the consensus estimate of $5.45 billion.
Outlook
There is significant uncertainty about the progression and ultimate impact of the pandemic on Gileads business and operations. While COVID-19 did not materially impact Gileads first quarter results, Gilead... More
